Profile data is unavailable for this security.
About the company
Uni-Bio Science Group Limited is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company operates through four segments. In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of in-house chemical pharmaceutical products. Its chemical pharmaceutical products include Pinapu, among others. In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological pharmaceutical products. Its biological pharmaceutical products include GeneTime and GeneSoft, among others. In-house Biological Pipeline segment is engaged in the industrialization of in-house biological pipeline. Its biological pipeline products include Uni-E4 and Uni-PTH, among others. Third-party Pharmaceutical Products segment is engaged in the sales of third-party pharmaceutical products.
- Revenue in HKD (TTM)508.40m
- Net income in HKD98.86m
- Incorporated2001
- Employees458.00
- LocationUni-Bio Science Group Ltd13/F, Public Bank Centre,120 Des Voeux Road Central, Central Hong KongHKG
- Phone+852 31023232
- Fax+852 31023737
- Websitehttps://www.uni-bioscience.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shenzhen Neptunus Intrlng Bi tchnq CoLtd | 1.16bn | 35.29m | 243.31m | 1.47k | 6.90 | 0.2343 | 665.70 | 0.2104 | 0.021 | 0.021 | 0.6893 | 0.6188 | 0.7383 | 3.11 | 3.99 | 801,019.30 | 1.73 | 3.46 | 2.56 | 5.13 | 37.47 | 49.14 | 2.34 | 4.29 | 2.20 | 29.81 | 0.082 | 0.00 | 7.92 | 4.19 | -55.60 | -12.89 | -11.10 | -- |
PuraPharm Corp Ltd | 419.41m | -87.09m | 296.92m | 525.00 | -- | 2.28 | -- | 0.708 | -0.2205 | -0.2205 | 1.06 | 0.3296 | 0.4854 | 1.15 | 5.93 | 633,542.30 | -10.08 | -9.20 | -30.69 | -19.70 | 51.97 | 59.52 | -20.77 | -19.33 | 0.3116 | -1.42 | 0.7597 | -- | -9.20 | -11.41 | 11.76 | -- | -13.68 | -- |
Hin Sang Group (Interntnl) Hldng Co Ltd | 92.62m | -36.71m | 322.08m | 247.00 | -- | 1.54 | -- | 3.48 | -0.0336 | -0.0336 | 0.0848 | 0.1913 | 0.1536 | 2.34 | 10.34 | 374,967.60 | -6.04 | -5.11 | -9.78 | -7.04 | 61.98 | 59.72 | -39.30 | -28.42 | 0.1287 | -1.68 | 0.6054 | -- | 13.70 | -12.83 | 25.84 | -- | -69.21 | -- |
Tianda Pharmaceuticals Ltd | 384.68m | -47.26m | 419.26m | 695.00 | -- | 0.7699 | -- | 1.09 | -0.022 | -0.022 | 0.1789 | 0.2533 | 0.4341 | 2.97 | 4.46 | 445,745.10 | -5.34 | -- | -7.97 | -- | 45.83 | -- | -12.30 | -- | 0.6748 | -9.51 | 0.1536 | -- | -- | -- | -- | -- | -- | -- |
Uni-Bio Science Group Ltd | 508.40m | 98.86m | 480.76m | 458.00 | 4.91 | 1.54 | 4.04 | 0.9456 | 0.0159 | 0.0159 | 0.0812 | 0.0507 | 1.27 | 2.23 | 12.21 | 1,249,140.00 | 24.76 | 1.46 | 32.97 | 1.97 | 83.51 | 80.59 | 19.44 | 1.23 | 2.17 | 168.55 | 0.2267 | 0.00 | 10.08 | 29.08 | 84.04 | -- | 84.98 | -- |
Transcenta Holding Ltd | 24.51m | -393.64m | 495.69m | 200.00 | -- | 0.4658 | -- | 20.23 | -0.9694 | -0.9694 | 0.0604 | 2.45 | 0.0131 | 0.8106 | 0.5768 | 113,990.50 | -21.08 | -- | -29.77 | -- | 26.02 | -- | -1,606.19 | -- | 1.04 | -31.65 | 0.2826 | -- | -47.15 | -- | -13.72 | -- | -- | -- |
Fusen Pharmaceutical Co Ltd | 467.01m | -98.42m | 709.73m | 1.14k | -- | 1.26 | -- | 1.52 | -0.132 | -0.132 | 0.6269 | 0.7617 | 0.3212 | 1.68 | 5.01 | 406,807.00 | -6.77 | 0.9678 | -13.96 | 1.74 | 53.18 | 51.95 | -21.08 | 2.59 | 0.526 | -2.10 | 0.4031 | 27.95 | 15.02 | 4.13 | -4.83 | -- | 0.2124 | -- |